International Journal of Infectious Diseases, March 2022. 116 (Supplement), S40. Efimenko, Nackeeran, Jabori, Gonzalez Zamora, Danker, Singh
This study followed 41,608 patients with Covid. 40,536 were treated with Remdesivir, and 1,072 were treated with Ivermectin. Results were controlled for a number of possible confounds such as diabetes,
Ivermectin had a 70% decreased mortality, with p<0.0001 (which means there is only a 1 in 10,000 chance this could have been a coincidence or accident.)
CONCLUSION: “Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir.”
The same video discusses a second study about prevention of Covid via Ivermectin. See Kerr et al (2022).
I am grateful this video has not been removed (yet) from Youtube. Watch it while you can.
EDITED 3/19/2022: Unfortunately, the “fact checkers” decided that they don’t like this video, and they have removed it altogether. So instead of Dr. Campbell leading you through the study, spend a few minutes reading it yourself before it, too, is removed. Such is the state of science today.
